for insomnia in Parkinson disease:results from an openlabel trial[J].Clin Neuropharmacol,2005,28:185
[18] Connemann BJ,SchonfeldtLecuona C.Ziprasidone in Parkinson’s disease psychosis[J].Can J Psychiatry,2004,49(1):73
[19] Shiah IS,Lin CL,Mao WC,et al.Ziprasidone in the treatment of Parkinson’s disease psychosis[J].Eur Psychiatry,2006,21:578
[20] Weiden PJ,Iqbal N, Mendelowitz AJ,et al.Best clinical practice with ziprasidone: update after one year of experience[J].J Psychiatr Pract, 2002,8(2):81
[21] SchonfeldtLecuona C,Connemann BJ.Aripiprazole and Parkinson’s disease psychosis[J].Am J Psychiatry,2004,161:373
[22] Wickremaratchi M,Morris HR.Aripiprazole associated with severe exacerbation of Parkinson’s disease[J].Mov Disord,2006,21(9):1538
[23] LopezMeza E,RuizChow A,RamirezBermudez J.Aripiprazole in psychosis associated with Parkinson’s disease[J].J Neuropsychiatry Clin Neurosci,2005,17(3):421
[24] Fernandez HH,Trieschmann ME,Friedman JH.Aripiprazole for druginduced psychosis in Parkinson disease: preliminary experience[J].Clin Neuropharmacol,2004,27:4
[25] Friedman JH,Berman RM,Goetz CG,et al.Openlabel flexibledose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson’s disease[J].Mov Disord,2006,21(12):2078
[26] Schneider LS,Dagerman KS,Insel P.Risk of death with atypical antipsychotic drug treatment for dementia: metaanalysis of randomized placebocontrolled trials[J].JAMA,2005,294(15):1934
仁和医学论文网专业提供代写代发医学论文服务，并提供大量论文资料，如有业务需求请咨询网站客服人员！
上一页 [1] [2] [3] [4]
您现在的位置： 绿色健康网 >> 医学论文 >> 外科论文 >> 正文